Glycemic and non-glycemic benefits of initial triple therapy versus sequential add-on therapy in patients with new-onset diabetes: results from the EDICT study

Introduction To compare carotid intima–media thickness (cIMT) and liver fat content in subjects who maintained good glycemic control for 6 years on initial triple therapy with metformin/exenatide/pioglitazone versus sequential add-on therapy with metformin followed with glipizide and basal insulin i...

ver descrição completa

Detalhes bibliográficos

Principais autores:	JOHN ADAMS, Ralph A DeFronzo, Aurora Merovci, Curtis Triplitt, Muhammad Abdul-Ghani, Curtiss Puckett, Siham Abdelgani, Olga Lavrynenko
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMJ Publishing Group 2025-04-01
coleção:	BMJ Open Diabetes Research & Care
Acesso em linha:	https://drc.bmj.com/content/13/2/e004981.full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!